Gene · 7392
Papers1,739
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,739
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into Hepatocellular Carcinoma in Patients with Thalassemia: From Pathophysiology to Novel Therapies. | Int J Mol Sci | 2023 | 37628834 | PubTator, text mining | PubMed |
| Regulation of 4-HNE via SMARCA4 Is Associated with Worse Clinical Outcomes in Hepatocellular Carcinoma. | Biomedicines | 2023 | 37626774 | PubTator, text mining | PubMed |
| Duplex loop-mediated isothermal amplification assay for simultaneous detection of human and human male DNA. | BMC Res Notes | 2023 | 37608397 | PubTator, text mining | PubMed |
| Autophagy and Glycometabolic Reprograming in the Malignant Progression of Lung Cancer: A Review. | Technol Cancer Res Treat | 2023 | 37605558 | PubTator, text mining | PubMed |
| E-box binding transcription factors in cancer. | Front Oncol | 2023 | 37601651 | PubTator, text mining | PubMed |
| LINC02015 modulates the cell proliferation and apoptosis of aortic vascular smooth muscle cells by transcriptional regulation and protein interaction network. | Cell Death Discov | 2023 | 37596272 | PubTator, text mining | PubMed |
| The Role of Cathepsin B in Pathophysiologies of Non-tumor and Tumor tissues: A Systematic Review. | J Cancer | 2023 | 37576397 | PubTator, text mining | PubMed |
| Establishment and Molecular Characterization of an In Vitro Model for PARPi-Resistant Ovarian Cancer. | Cancers (Basel) | 2023 | 37568590 | PubTator, text mining | PubMed |
| Syntaxin-6 promotes the progression of hepatocellular carcinoma and alters its sensitivity to chemotherapies by activating the USF2/LC3B axis. | Int J Biol Sci | 2023 | 37564208 | PubTator, text mining | PubMed |
| Identifying cellular senescence associated genes involved in the progression of end-stage renal disease as new biomarkers. | BMC Nephrol | 2023 | 37553608 | PubTator, text mining | PubMed |
Analytical and diagnostic performance characteristics of reverse-transcriptase loop-mediated isothermal amplification assays for dengue virus serotypes 1-4: A scoping review to inform potential use in portable molecular diagnostic devices. | PLOS Glob Public Health | 2023 | 37552632 | PubTator, text mining | PubMed |
| Multi-omics profiling of CSF from spinal muscular atrophy type 3 patients after nusinersen treatment: a 2-year follow-up multicenter retrospective study. | Cell Mol Life Sci | 2023 | 37543540 | PubTator, text mining | PubMed |
| Semi-infectious particles contribute substantially to influenza virus within-host dynamics when infection is dominated by spatial structure. | Virus Evol | 2023 | 37538918 | PubTator, text mining | PubMed |
| Surface Conversion of ZnO Tetrapods Produces Pinhole-Free ZIF-8 Layers for Selective and Sensitive H2 Sensing Even in Pure Methane. | ACS Appl Mater Interfaces | 2023 | 37527811 | PubTator, text mining | PubMed |
| Genetic impacts on DNA methylation help elucidate regulatory genomic processes. | Genome Biol | 2023 | 37525248 | PubTator, text mining | PubMed |
| Improved Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) for the Rapid and Sensitive Detection of Yam mosaic virus. | Viruses | 2023 | 37515278 | PubTator, text mining | PubMed |
| Upstream Stimulatory Factors Regulate HIV-1 Latency and Are Required for Robust T Cell Activation. | Viruses | 2023 | 37515158 | PubTator, text mining | PubMed |
| Sample Treatment with Trypsin for RT-LAMP COVID-19 Diagnosis. | Biology (Basel) | 2023 | 37508333 | PubTator, text mining | PubMed |
| Rapid and visual identification of HIV-1 using reverse transcription loop-mediated isothermal amplification integrated with a gold nanoparticle-based lateral flow assay platform. | Front Microbiol | 2023 | 37502395 | PubTator, text mining | PubMed |
| Identification of mammalian transcription factors that bind to inaccessible chromatin. | Nucleic Acids Res | 2023 | 37486787 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7392/papers?page=8